Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-10-06
1989-05-02
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514256, 544333, 546 68, A61K 3148, C07D45712
Patent
active
048268518
ABSTRACT:
Novel 2-substituted ergolinyl urea and thioruea derivatives are disclosed, as well as their use as pharmaceuticals, specifically as neuroleptics. The compounds, which possess central dopaminergic activity, have the formula ##STR1## wherein X is an oxygen or sulfur atom,
REFERENCES:
patent: 3029243 (1962-04-01), Olin
patent: 3251846 (1966-05-01), Semonsky et al.
patent: 3821226 (1974-06-01), Fehu et al.
patent: 3953454 (1976-04-01), Zikan et al.
patent: 4382940 (1983-05-01), Bernardi et al.
patent: 4500712 (1985-02-01), Bernardi et al.
Berde et al., Ergot Alkaloids and Related Compounds, Springer-Verlag, New York (1978), pp. 74, 469-470.
Pratt et al., Organosilicon Compounds, XX, J. Org. Chem., vol. 40 (1975), pp. 1090-1093.
Huth Andreas
Sauer Gerhard
Wachtel Helmut
Gerstl Robert
Schering Aktiengesellschaft
Shen Cecilia
LandOfFree
2-substituted ergoline urea and thio-urea derivatives having neu does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-substituted ergoline urea and thio-urea derivatives having neu, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-substituted ergoline urea and thio-urea derivatives having neu will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-585220